Clinical Trials Sponsored by Farmer Foundation

Total 18014 results

Dana-Farber Cancer Institute

Completed

Smart Phone App Intervention In Young Adults With Cancer

Cancer | Young Adults | Smartphone Application | Behavioral Intervention

United States
Dana-Farber Cancer Institute

Withdrawn

Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas

Soft Tissue Sarcoma

United States
Dana-Farber Cancer Institute

Completed

FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

Gastric Cancer | Esophageal Cancer

United States
Dana-Farber Cancer Institute

Completed

Personal Web Page In Clinical Trial Participant Education

Kidney Cancer | Prostate Cancer | Genitourinary Cancer

United States
Dana-Farber Cancer Institute

Completed

Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate

CNS Lymphoma | CNS Involvement of Systemic Lymphoma

United States
Dana-Farber Cancer Institute

Terminated

Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors

Fatigue in Cancer Survivors

United States
Dana-Farber Cancer Institute

Completed

A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulatory Oncology Setting

Anxiety

United States
Dana-Farber Cancer Institute

Completed

Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Glioblastoma

United States
Dana-Farber Cancer Institute

Completed

Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials

Non-Hodgkin's Lymphoma

United States
Dana-Farber Cancer Institute

Completed

Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients

Low Level Light Therapy | Oropharyngeal Mucositis | Myeloablative Hematopoietic Cell Transplantation

United States
Dana-Farber Cancer Institute

Terminated

Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

Healthy Living After Cancer: Weight Management Pilot Study

Weight Loss Program After Cancer Diagnosis

United States
Dana-Farber Cancer Institute

Withdrawn

Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma

Squamous Cell Carcinoma of the Oropharynx

United States
Dana-Farber Cancer Institute

Withdrawn

Clofarabine for Langerhans in Pedi

Langerhans Cell Histiocytosis
Dana-Farber Cancer Institute

Completed

Melatonin Versus Placebo in Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute

Completed

iCAT for Recurrent/Refractory/HR Solid Tumors

Sarcoma | Neuroblastoma | Wilms Tumor | Pediatric Solid Tumor

United States
Dana-Farber Cancer Institute

Terminated

Dasatinib in Advanced Squamous Cell Lung Cancer

Squamous Cell Lung Cancer

United States
Dana-Farber Cancer Institute

Completed

SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)

Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma

United States
Dana-Farber Cancer Institute

Completed

Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma

Melanoma (Skin)

United States
Dana-Farber Cancer Institute

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Myelodysplastic Syndromes | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Graft Versus Host Disease | Hodgkin's Disease

United States
Dana-Farber Cancer Institute
Gateway for Cancer Research; Susan G. Komen Breast Cancer Foundation

Active, not recruiting

ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer

Breast Cancer

United States
Simon Fraser University
Fraser Health

Completed

Preventing Risk for Metabolic Syndrome in Workaholics: An Intervention

PreDiabetes

Canada
Fundacion Miguel Servet
Hospital Universitario Getafe; Matia Foundation

Unknown

Impact of a Multicomponent Exercise Program on Functional Capacity in Frail Aged Participants With Cognitive Decline

Cognitive Impairment | Frail Elderly Syndrome

Spain
Parker Research Institute
Oak Foundation; The Danish Rheumatism Association; Aase and Ejnar Danielsens... and other collaborators

Completed

Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial (RAHExercise)

Rheumatoid Arthritis

Denmark
Calmy Alexandra
University Hospital, Geneva; Swiss National Science Foundation; Swiss Heart Foundation and other collaborators

Terminated

ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART (NILACH)

Atherosclerosis | HIV

Switzerland
Glenn J. Hanna
Adenoid Cystic Carcinoma Research Foundation; Cellestia Biotech AG

Recruiting

CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

Adenoid Cystic Carcinoma | Metastatic Adenoid Cystic Carcinoma | Recurrent Adenoid Cystic Carcinoma

United States
Fraser Health

Recruiting

The Application of Ketamine for Sedation in Patients With Cardiac Arrest - - KetCat (KETamine in Cardiac ArresT) Study (KetCat)

Neurologic Manifestations | Ketamine | Cardiac Arrest, Out-Of-Hospital

Canada
Parker University

Completed

Effect of Lower Extremity Joint Manipulation on a Lower Extremity Somatosensory Illusion

Healthy | Coordination and Balance Disturbances

United States
Parker University

Completed

Nutrient Nutritional Advise for Low Back Pain Patients Seeking Chiropractic Care

Low Back Pain | Nutrition Poor

United States
Fraser Health

Completed

A Feasibility Study of a Suicide Prevention Video

Suicidal Ideation | Psychiatric Illness | Suicide Attempts

Canada
Marmur Medical

Completed

Hyaluronic Acid Filler for Dorsal Finger Volume Loss

Personal Satisfaction

United States
Fraser Health

Completed

Seniors Driving Cessation Early Intervention Group

Depression | Quality of Life

Canada
Warner Chilcott

Completed

A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

Menopause | Vulvovaginal Atrophy | Dyspareunia

United States
Warner Chilcott

Completed

Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Fraser Health

Completed

Pilot Study of Vitamin D Supplementation in Heart Failure

Heart Failure

Canada
Fraser Health

Completed

PCT and Clinical Algorithm for Determination of Duration of Antibiotics

Infection

Canada
Warner Chilcott

Completed

Treatment of Erectile Dysfunction - Long Term Safety and Efficacy

Erectile Dysfunction

United States
Warner Chilcott

Terminated

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

Erectile Dysfunction

United States
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Contraception

United States
Warner Chilcott

Completed

Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.

Hormone Replacement Therapy

United States
Warner Chilcott

Completed

Study of Safety and Efficacy of an Oral Contraceptive

Prevention of Pregnancy

United States
Warner Chilcott

Completed

Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

United States
Warner Chilcott

Completed

Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch

Healthy

United States
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

United States, Canada, Australia
Warner Chilcott

Completed

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Hypoactive Sexual Desire Disorder

Canada, Australia, United States
Warner Chilcott

Completed

Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen

Hypoactive Sexual Desire Disorder

Australia, Botswana, Canada, Germany, United Kingdom
Warner Chilcott

Terminated

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis (CAMPIII)

Ulcerative Colitis

United States, Canada, Croatia, Russian Federation, Poland, Romania
Warner Chilcott

Completed

Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Acne Vulgaris

United States
Warner Chilcott

Completed

Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis

Ulcerative Colitis

Poland, United States, Croatia, Romania, Canada
Warner Chilcott

Completed

Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate

Postmenopausal Women

United States

Clinical Trials Sponsored by Farmer Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations